Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes ; day:1 ; month:12 ; year:2021 ; pages:1-5
Clinical research in cardiology ; (1.12.2021), 1-5
- Creator
-
Ndrepepa, Gjin
Holdenrieder, Stefan
Bernlochner, Isabell
Kastrati, Adnan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-021-01976-y
- URN
-
urn:nbn:de:101:1-2022020518030404826251
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ndrepepa, Gjin
- Holdenrieder, Stefan
- Bernlochner, Isabell
- Kastrati, Adnan
- SpringerLink (Online service)
Other Objects (12)
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Long-term outcome after coronary stenting
High on-Aspirin Treatment Platelet Reactivity und In-Stent Restenosen – Ergebnisse des ISAR-ASPI Registers
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
Understanding the genetics of coronary artery disease through novel statistical approaches
Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
Metabolism of ticagrelor in patients with acute coronary syndromes
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Long-term outcome after coronary stenting
High on-Aspirin Treatment Platelet Reactivity und In-Stent Restenosen – Ergebnisse des ISAR-ASPI Registers
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
Understanding the genetics of coronary artery disease through novel statistical approaches
Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
Metabolism of ticagrelor in patients with acute coronary syndromes
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Long-term outcome after coronary stenting
High on-Aspirin Treatment Platelet Reactivity und In-Stent Restenosen – Ergebnisse des ISAR-ASPI Registers
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
Understanding the genetics of coronary artery disease through novel statistical approaches
Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
Metabolism of ticagrelor in patients with acute coronary syndromes
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel